DECIPHERA PHARMACEUTICALS, INC. FORM OF DIRECTOR INDEMNIFICATION AGREEMENTDirector Indemnification Agreement • September 22nd, 2017 • Deciphera Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (this “Agreement”) is made as of by and between Deciphera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and (“Indemnitee”).
DECIPHERA PHARMACEUTICALS, INC. FORM OF OFFICER INDEMNIFICATION AGREEMENTOfficer Indemnification Agreement • September 22nd, 2017 • Deciphera Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (this “Agreement”) is made as of by and between Deciphera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and (“Indemnitee”).
PIPER JAFFRAY & CO. DECIPHERA PHARMACEUTICALS, INC. DECIPHERA PHARMACEUTICALS, LLC [●] Shares of common stock, par value $0.01 per share Underwriting AgreementUnderwriting Agreement • September 22nd, 2017 • Deciphera Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Deciphera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [●] shares of common stock, par value $0.01 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [●] shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
